Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Michael H. Andreae. (2018) Contextualizing and Individualizing Truth-Telling About Pain in a Tough and Unjust World. AJOB Neuroscience 9:3, pages 190-192.
Read now
Read now
Daniel Steel, Kirsten Marchand & Eugenia Oviedo-Joekes. (2017) Our Life Depends on This Drug: Competence, Inequity, and Voluntary Consent in Clinical Trials on Supervised Injectable Opioid Assisted Treatment. The American Journal of Bioethics 17:12, pages 32-40.
Read now
Read now
Michael H. Andreae, Evelyn Rhodes, Tyler Bourgoise, George M. Carter, Robert S. White, Debbie Indyk, Henry Sacks & Rosamond Rhodes. (2016) Research With Controlled Drugs: Why and Why Not? Response to Open Peer Commentaries on “An Ethical Exploration of Barriers to Research on Controlled Drugs”. The American Journal of Bioethics 16:4, pages W1-W3.
Read now
Read now
Leslie Francis & John Francis. (2016) Justice and Research on Controlled Substances With HIV+ Persons. The American Journal of Bioethics 16:4, pages 52-54.
Read now
Read now
Evert van Leeuwen. (2016) Research on Controlled Drug Use: A Paradigm for Public Health Research in Sustainable Health. The American Journal of Bioethics 16:4, pages 50-52.
Read now
Read now
Ruth Macklin. (2016) NIDA's Pharmacologic Calvinism. The American Journal of Bioethics 16:4, pages 48-49.
Read now
Read now
Danton Char. (2016) Supervised Controlled Substance Use. The American Journal of Bioethics 16:4, pages 56-58.
Read now
Read now
Andrea Segal & Dominic Sisti. (2016) Research Moratoria and Off-Label Use of Ketamine. The American Journal of Bioethics 16:4, pages 60-61.
Read now
Read now
Andrew Plunk & Paul T. Harrell. (2016) Barriers To Research Using Controlled Drugs Are Not Created Equal. The American Journal of Bioethics 16:4, pages 54-56.
Read now
Read now
Articles from other publishers (25)
Christiane Martins de Vasconcellos Silveira, Vanessa Farelo dos Santos, Isis Moraes Ornelas, Beatriz de Sá Carrilho, Matheus Antonio Vieira de Castro Ventura, Henrique Marcelo Gualberto Pereira, Stevens Kastrup Rehen & Magno Junqueira. (2023) Systematic characterization of Lysergic Acid Diethylamide metabolites in Caenorhabditis elegans by ultra-high performance liquid chromatography coupled with high-resolution tandem mass spectrometry. Journal of Chromatography A 1708, pages 464362.
Crossref
Crossref
Taylor T. Sivori, Maclain Capron, Daniel Graves, Jill Harris & Roseann C. Schaaf. (2023) Caregivers' views on cannabis use for their children with autism. Research in Autism Spectrum Disorders 102, pages 102130.
Crossref
Crossref
Yatan Pal Singh Balhara, Siddharth Sarkar & Shalini Singh. (2022) Medical Use, Decriminalization, and Legalization of Narcotic Drugs and Psychotropic Substances—What Does It Mean and What Is Its Current Status in India?. Indian Journal of Psychological Medicine 45:2, pages 179-184.
Crossref
Crossref
Marlize Krüger, Tertia van Eeden & Daniso Beswa. (2022) Cannabis sativa Cannabinoids as Functional Ingredients in Snack Foods—Historical and Developmental Aspects. Plants 11:23, pages 3330.
Crossref
Crossref
Katherine Y. C. Cheng, Joanna E. Harnett, Sharon R. Davis, Daniela Eassey, Susan Law & Lorraine Smith. (2022) Healthcare professionals' perspectives on the use of medicinal cannabis to manage chronic pain: A systematic search and narrative review. Pain Practice 22:8, pages 718-732.
Crossref
Crossref
Thomas A Clobes, Mya Arellano, Matin Gagnon & Colby Klaiman. (2022) Differences in Attitudes Toward Medical Cannabis With Humanized Patient Scenarios. Cureus.
Crossref
Crossref
Michelle N Anyaehie, Christian Pardo, Daniel E Kaufman & Brian J Piper. (2022) Opioid Distribution Trends in California Following Recreational Cannabis Legalization. The Guthrie Journal 74:1.
Crossref
Crossref
Casey Basham, Audrey Cerles, Margaret Rush, Marissa Alexander-Scott, Lee Greenawald, Sophia Chiu, Kendra Broadwater, Deborah Hirst, John Snawder, Jennifer Roberts, Angela Weber, Martha Knuth & Rocco Casagrande. (2021) Occupational Safety and Health and Illicit Opioids: State of the Research on Protecting Against the Threat of Occupational Exposure. NEW SOLUTIONS: A Journal of Environmental and Occupational Health Policy 31:3, pages 315-329.
Crossref
Crossref
Morgan Campbell & Monnica T. Williams. (2021) The Ethic of Access: An AIDS Activist Won Public Access to Experimental Therapies, and This Must Now Extend to Psychedelics for Mental Illness. Frontiers in Psychiatry 12.
Crossref
Crossref
Evgeny Bulat, Rohan Jotwani, Roniel Weinberg, Michael A Akerman & Robert S White. (2021) Cannabis, anesthesia and acute postoperative pain: known and unknown. Pain Management 11:4, pages 341-346.
Crossref
Crossref
Brandon R. McFadden & Trey Malone. (2021) Homegrown perceptions about the medical use and potential abuse of CBD and THC. Addictive Behaviors 115, pages 106799.
Crossref
Crossref
Kelly McGlothen-Bell, Lisa Cleveland, Pamela Recto, Elizabeth Brownell & Jacqueline McGrath. (2020) Feeding Behaviors in Infants With Prenatal Opioid Exposure. Advances in Neonatal Care 20:5, pages 374-383.
Crossref
Crossref
Nicole S. Jones & Jeffrey H. Comparin. (2020) Interpol review of controlled substances 2016–2019. Forensic Science International: Synergy 2, pages 608-669.
Crossref
Crossref
Andrew J. Polis, Paul J. Fitzgerald, Pho J. Hale & Brendon O. Watson. (2019) Rodent ketamine depression-related research: Finding patterns in a literature of variability. Behavioural Brain Research 376, pages 112153.
Crossref
Crossref
Harish A. Lingam & Robert L. Caudill. (2019) Teleprescribing Controlled Substances: Flowchart Analysis of the Ryan Haight Act and State Telemedicine Laws. Journal of Technology in Behavioral Science 4:4, pages 346-359.
Crossref
Crossref
Chi-Tsan Wang, Christine Wiedinmyer, Kirsti Ashworth, Peter C. Harley, John Ortega, Quazi Z. Rasool & William Vizuete. (2019) Potential regional air quality impacts of cannabis cultivation facilities in Denver, Colorado. Atmospheric Chemistry and Physics 19:22, pages 13973-13987.
Crossref
Crossref
Ruff Joseph Macale Cajanding. (2019) MDMA-Associated Liver Toxicity: Pathophysiology, Management, and Current State of Knowledge. AACN Advanced Critical Care 30:3, pages 232-248.
Crossref
Crossref
Kristóf János Bodnár & Péter Kakuk. (2018) Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review. Medicine, Health Care and Philosophy 22:2, pages 327-337.
Crossref
Crossref
Rebecca Morland. (2019) Evolution of the national opioid crisis. Nursing 49:5, pages 51-56.
Crossref
Crossref
Estefanía Moreno, Milena Cavic, Ana Krivokuca, Vicent Casadó & Enric Canela. (2019) The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?. Frontiers in Pharmacology 10.
Crossref
Crossref
Jeff Victoroff. 2019. Concussion and Traumatic Encephalopathy. Concussion and Traumatic Encephalopathy
422
495
.
Daniel E. Graves. (2018) Cannabis shenanigans: advocating for the restoration of an effective treatment of pain following spinal cord injury. Spinal Cord Series and Cases 4:1.
Crossref
Crossref
Jane O’Doherty & Ray O’Connor. (2018) The case for medicinal cannabis. Irish Journal of Medical Science (1971 -) 187:2, pages 539-540.
Crossref
Crossref
Ilina Singh, Celia Morgan, Valerie Curran, David Nutt, Anne Schlag & Rupert McShane. (2017) Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight. The Lancet Psychiatry 4:5, pages 419-426.
Crossref
Crossref
Sarah See StithJacob Miguel Vigil. (2016)
Federal barriers to
Cannabis
research
. Science 352:6290, pages 1182-1182.
Crossref
Crossref